Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

The Role of Coagulation Gene Polymorphisms in Sars-CoV2 Infection in the Bergamo Area

Marina Marchetti, Chiara Villa, Sara Gamba, Donatella Conconi, Cinzia Giaccherini, Laura Russo, Silvia Bolognini, Carmen Julia Tartari, Chiara Ticozzi, Cristina Verzeroli, Francesca Schieppati, Luca Barcella, Marialuisa Lavitrano, Anna Falanga

Blood (2023) 142 (Supplement 1): 5410.

https://doi.org/10.1182/blood-2023-185934

Published: 2023

Journal Articles

A D-Dimer and Thrombin Generation-Based Risk Score Predicts Early-Disease Recurrence in a Prospective Cohort of 1,059 High-Risk Breast Cancer Patients

Blood (2023) 142 (Supplement 1): 5460.

https://doi.org/10.1182/blood-2023-186332

Published: 2023

Journal Articles

Role of Hemostatic Biomarkers for the Identification of Patients with LONG-COVID19 Syndrome: Results from the 'Accordi' Study

Chiara Ambaglio, Marina Marchetti, Simone V Benatti, Carmen J Tartari, Cinzia Giaccherini, Laura Russo, Sara Gamba, Cristina Verzeroli, Silvia Bolognini, Chiara Ticozzi, Francesca Schieppati, Serena Venturelli, Luca Barcella, Marco Rizzi, Anna Falanga

Blood (2022) 140 (Supplement 1): 2652–2653.

https://doi.org/10.1182/blood-2022-162206

Published: 2022

Journal Articles

Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry

Marina Marchetti, Angela Maria Palladino, Carmen J Tartari, Laura Russo, Cinzia Giaccherini, Sara Gamba, Silvia Bolognini, Cristina Verzeroli, Chiara Ticozzi, Oana Cristina Cretu, Francesca Schieppati, Luca Barcella, Anna Falanga

Blood (2022) 140 (Supplement 1): 2660–2661.

https://doi.org/10.1182/blood-2022-160202

Published: 2022

Journal Articles

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience

Carmen Julia J Tartari, Giulia Milani, Francesco Salvetti, Marina Marchetti, Laura Russo, Alfonso Vignoli, Massimiliano Vitali, Francesca Schieppati, Giulia Ravasio, Laura Castellani, Eleonora Sanga, Debora Romeo, Anna Falanga

Blood (2021) 138 (Supplement 1): 1054.

https://doi.org/10.1182/blood-2021-153611

Published: 2021

Journal Articles

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination

Francesca Schieppati, Laura Russo, Marina Marchetti, Elisa Galimberti, Angela Maria Palladino, Sara Gamba, Cristina Verzeroli, Carmen Julia J Tartari, Silvia Bolognini, Chiara Ticozzi, Cinzia Giaccherini, Luca Barcella, Anna Falanga

Blood (2021) 138 (Supplement 1): 1022.

https://doi.org/10.1182/blood-2021-153606

Published: 2021

Journal Articles

Thrombin Generation and D-Dimer Significantly Predict for Early Disease Progression and Mortality in Patients with Gastrointestinal Cancer

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-136631

Published: 2020

Journal Articles

Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital

Patricia Gomez-Rosas, MD, Marina Marchetti, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Laura Russo, Francesco Restuccia, Andrea D'Alessio, Ezio Bonanomi, Marco Rizzi, Stefano Fagiuoli, Luca Lorini, Anna Falanga, MD

Blood (2020) 136 (Supplement 1): 36.

https://doi.org/10.1182/blood-2020-136724

Published: 2020

Journal Articles

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

Blood (2019) 134 (Supplement_1): 3642.

https://doi.org/10.1182/blood-2019-129901

Published: 2019

Journal Articles

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Blood (2019) 134 (Supplement_1): 2426.

https://doi.org/10.1182/blood-2019-129820

Published: 2019

Journal Articles

Pre-Chemotherapy Levels of Hemostatic Biomarkers and Prediction of Prognosis in Newly Diagnosed Metastatic Cancer Patients from the Hypercan Study

Blood (2018) 132 (Supplement 1): 3795.

https://doi.org/10.1182/blood-2018-99-118374

Published: 2018

Journal Articles

Combined Elevated Anti-Adamts-13 Antibody Level and Low Adamts-13 Activity during Remission Highly Predicts Disease Relapse in a Prospective Cohort of Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (TTP)

Francesca Schieppati, MD, Laura Russo, Marina Marchetti, Gloria Caldara, Shenaz Brevi, Maria Testa, Luca Barcella, Monica Carpenedo, Mariella D'Adda, Giuseppe Rossi, Chiara Savignano, Atto Billio, Massimiliano Bruno Franco, Vincenzo Toschi, Anna Falanga

Blood (2018) 132 (Supplement 1): 2443.

https://doi.org/10.1182/blood-2018-99-119317

Published: 2018

Journal Articles

Prospective Evaluation of Thrombo-Hemorrhagic Events and Hypercoagulation Markers in Patients with Acute Promyelocytic Leukemia (APL) Receiving All-Trans Retinoic Acid (ATRA) Plus Chemotherapy

Anna Falanga, MD, Laura Russo, Marina Marchetti, Carmen J Tartari, Laura Castellani, Eros Di Bona, MD, Barry Woodhams, PhD MPhil, Alessandro Rambaldi, MD Prof, Francesco Lo Coco, MD

Blood (2017) 130 (Supplement 1): 3694.

https://doi.org/10.1182/blood.V130.Suppl_1.3694.3694

Published: 2017

Journal Articles

Effects of Antiplatelet Treatment with Aspirin (ASA) on Platelet Reactivity in Patients with Essential Thrombocythemia

Marina Marchetti, MSc, PhD, Sara Gamba, MSc, Cinzia Giaccherini, MSc, Cristina Verzeroli, MSc, Laura Russo, MSc, Carmen Julia Tartari, MSc, PhD, Alfonso Vignoli, MSc, Guido Finazzi, MD, Alessandro Rambaldi, MD, Anna Falanga, MD

Blood (2016) 128 (22): 4253.

https://doi.org/10.1182/blood.V128.22.4253.4253

Published: 2016

Journal Articles

Hypercoagulation Screening as Marker of Occult Cancer in a Population of Healthy Blood Donors: The Hypercan Prospective Study

Anna Falanga, MD, Marina Marchetti, MSc, PhD, Sara Gamba, MSc, Laura Russo, MSc, Carmen Julia Tartari, MSc, PhD, Cinzia Giaccherini, MSc, Cristina Verzeroli, MSc, Francesca Piras, MSc, Viola Milesi, MD, Alfonso Vignoli, MSc, Shenaz Brevi, Francesca Rio, Luca Barcella, MD, Giuseppe Sampietro

Blood (2016) 128 (22): 2604.

https://doi.org/10.1182/blood.V128.22.2604.2604

Published: 2016

Journal Articles

JAK2V617F Mutation and Thrombosis History Are Determinants of Mean Platelet Volume (MPV) in Essential Thrombocythemia Patients

Marina Marchetti, MSc, PhD, Cristina Verzeroli, MSc, Cinzia Giaccherini, MSc, Sara Gamba, MSc, Alfonso Vignoli, MSc, Laura Russo, MSc, Guido Finazzi, MD, Alessandro Rambaldi, MD, Anna Falanga, MD

Blood (2016) 128 (22): 2606.

https://doi.org/10.1182/blood.V128.22.2606.2606

Published: 2016

Journal Articles

Measurement of Thrombin Generation Is a Positive Predictive Biomarker of V enous Thromboembolism ( VTE) in Metastatic Cancer Patients Enrolled in the Hypercan Study

Blood (2015) 126 (23): 654.

https://doi.org/10.1182/blood.V126.23.654.654

Published: 2015

Journal Articles

Low Molecular Weight Heparin Modulates Thrombin Generation in Cancer Patients Undergoing Antithrombotic Therapy for Overt Venous Thromboembolism

Anna Falanga, MD, Carmen J Tartari, PhD, Marina R Marchetti, PhD, Laura Russo, MBioSc, Kim WFM Lambregts, Davide Resta, MD, Andrea D'Alessio, MD

Blood (2014) 124 (21): 1539.

https://doi.org/10.1182/blood.V124.21.1539.1539

Published: 2014

Journal Articles

Activated FVII-Antithrombin Complex and Tissue Factor mRNA As Potential Markers of Severe Thrombo-Hemorrhagic Syndrome in APL Patients

Laura Russo, Marina Marchetti, PhD, Carmen Julia Tartari, PhD, Eros Di Bona, Alessandro Rambaldi, Francesco Lo Coco, Anna Falanga, MD

Blood (2011) 118 (21): 1195.

https://doi.org/10.1182/blood.V118.21.1195.1195

Published: 2011

Journal Articles

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

Marina Panova-Noeva, Marina Marchetti, Sabrina Buoro, Laura Russo, Annamaria Leuzzi, Guido Finazzi, Alessandro Rambaldi, Cosimo Ottomano, Hugo ten Cate, Anna Falanga

Blood (2011) 118 (9): 2599–2601.

https://doi.org/10.1182/blood-2011-02-339655

Published: 2011

NARROW

The Role of Coagulation Gene Polymorphisms in Sars-CoV2 Infection in the Bergamo Area

A D-Dimer and Thrombin Generation-Based Risk Score Predicts Early-Disease Recurrence in a Prospective Cohort of 1,059 High-Risk Breast Cancer Patients

Role of Hemostatic Biomarkers for the Identification of Patients with LONG-COVID19 Syndrome: Results from the 'Accordi' Study

Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry

Post-Covid-19 Hemostatic Characteristics of Convalescent Patients: The Bergamo Experience

Hemostatic Markers, Adamts-13 Profile and Anti-Sars-Cov-2 Antibody Levels in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving BNT162b2 Vaccination

Thrombin Generation and D-Dimer Significantly Predict for Early Disease Progression and Mortality in Patients with Gastrointestinal Cancer

Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital

Thrombotic Risk Assessment in a Prospective Cohort of Newly Diagnosed Ambulatory Cancer Patients Candidate to Chemotherapy

A Thrombotic Biomarker-Based Risk Assessment Scoring Model for Disease Recurrence in Breast Cancer Patient Candidate to Systemic Chemotherapy

Pre-Chemotherapy Levels of Hemostatic Biomarkers and Prediction of Prognosis in Newly Diagnosed Metastatic Cancer Patients from the Hypercan Study

Combined Elevated Anti-Adamts-13 Antibody Level and Low Adamts-13 Activity during Remission Highly Predicts Disease Relapse in a Prospective Cohort of Patients with Autoimmune Thrombotic Thrombocytopenic Purpura (TTP)

Prospective Evaluation of Thrombo-Hemorrhagic Events and Hypercoagulation Markers in Patients with Acute Promyelocytic Leukemia (APL) Receiving All-Trans Retinoic Acid (ATRA) Plus Chemotherapy

Effects of Antiplatelet Treatment with Aspirin (ASA) on Platelet Reactivity in Patients with Essential Thrombocythemia

Hypercoagulation Screening as Marker of Occult Cancer in a Population of Healthy Blood Donors: The Hypercan Prospective Study

JAK2V617F Mutation and Thrombosis History Are Determinants of Mean Platelet Volume (MPV) in Essential Thrombocythemia Patients

Measurement of Thrombin Generation Is a Positive Predictive Biomarker of V enous Thromboembolism ( VTE) in Metastatic Cancer Patients Enrolled in the Hypercan Study

Low Molecular Weight Heparin Modulates Thrombin Generation in Cancer Patients Undergoing Antithrombotic Therapy for Overt Venous Thromboembolism

Activated FVII-Antithrombin Complex and Tissue Factor mRNA As Potential Markers of Severe Thrombo-Hemorrhagic Syndrome in APL Patients

JAK2V617F mutation and hydroxyurea treatment as determinants of immature platelet parameters in essential thrombocythemia and polycythemia vera patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only